The Mamma HiToP Study

Status Recruiting

Clinical Trial Summary

The HiToP ® 191 PNP an certified device licensed for the treatment of neuropathia. The home-based treatment is to be performed only in accordance with the approved Investigational Plan (CIP) on subjects who have signed an informed consent form. Device use is limited to the approved study investigators. The study is multicenter, randomized, double-blind, and placebo-controlled. Primary Objective: Comparison of the change of paresthesias from baseline until end of therapy between the two patient groups, assessed by questionnaires Secondary Objectives: Further symptoms of neuropathy as well as on health-related quality of life.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Chemotherapy-induced Peripheral Neuropathy
Peripheral Nervous System Diseases

Clinical Trial Details

NCT number	NCT06132776
Study type	Interventional
Source	Vienna Hospital Association
Contact	Robert Wakolbinger-Habel, MD, PhD
Phone	+43 1 28802 4604
Email	robert.wakolbinger-habel@gesundheitsverbund.at
Status	Recruiting
Phase	N/A
Start date	November 3, 2023
Completion date	December 31, 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05528263` - Preventing Chemotherapy-Induced Peripheral Neuropathy With Acupuncture (PACT Trial)	N/A
Completed	`NCT03272919` - Chemotherapy Induced Peripheral Neuropathy (CIPN)	N/A
Not yet recruiting	`NCT06430814` - Clinical Biomarker of Paclitaxel-induced Peripheral Neuropathy
Not yet recruiting	`NCT05840562` - Capsaicin 179 mg Patch Versus Oral Duloxetine in Patients With Chemotherapy-induced Peripheral Neuropathy	Phase 3
Completed	`NCT02553863` - The Effectiveness and Cost-effectiveness of Acupuncture in Managing Chemotherapy-induced Peripheral Neuropathy	N/A
Recruiting	`NCT04786977` - Physiologic Measure of VIPN
Completed	`NCT03655587` - Impact of an Orthotic Intervention in Children With Peripheral Neuropathy	N/A
Completed	`NCT03687970` - A New Method for Identifying Sensory Changes in Painful Chemotherapy-induced Peripheral Neuropathy (CIPN)	N/A
Terminated	`NCT04770402` - Acupuncture for Chemo-Induced Peripheral Neuropathy in Multiple Myeloma Patients	N/A
Completed	`NCT03254394` - Lidocaine for Oxaliplatin-induced Neuropathy	Phase 1/Phase 2
Completed	`NCT04367480` - Effects of Transcutaneous Electrical Nerve Stimulation on Chemotherapy-Induced Peripheral Neuropathy	N/A
Recruiting	`NCT04237194` - A New Diagnostic Method to Assess Paclitaxel-Induced Peripheral Neuropathy
Completed	`NCT04843410` - Effect of Exercise in the Management of Peripheral Neuropathy	N/A
Terminated	`NCT03782402` - Cannabinoids for Taxane Induced Peripheral Neuropathy	Phase 2
Not yet recruiting	`NCT06389721` - Understanding and Preventing Cortical Mechanisms of Chemotherapy-induced Peripheral Neuropathy
Recruiting	`NCT05121558` - The Effect of Yoga on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropathy)	Phase 3
Withdrawn	`NCT04492436` - A Trial Measuring ART-123 Ability to Prevent Sensory Neuropathy in Unresectable mCRC Subjects w/Oxaliplatin-based Chemo	Phase 2
Not yet recruiting	`NCT03112057` - Visualize Nociceptor Changes in Neuropathic Human	N/A
Completed	`NCT04262778` - Diagnostic of Chemotherapy Induced Neuropathy in Children
Recruiting	`NCT06324344` - Transcutaneous Electrical Nerve Stimulation (TENS) for Chemotherapy Induced Peripheral Neuropathy (CIPN)	N/A